Method of modulating T cell-dependent immune responses

Details for Australian Patent Application No. 2009223850 (hide)

Owner Converge Biotech Inc.

Inventors Grassi, Fabio; Schenk, Urusla; Ricordi, Camillo

Agent Cullens

Pub. Number AU-A-2009223850

PCT Pub. Number WO2009/114097

Priority 61/200,944 05.12.08 US; 61/068,034 03.03.08 US

Filing date 3 March 2009

Wipo publication date 17 September 2009

International Classifications

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/7076 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

Event Publications

28 October 2010 PCT application entered the National Phase

  PCT publication WO2009/114097 Priority application(s): WO2009/114097

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223851-Methods of treating hyperacidic disorders

2009223847-Variable axis locking mechanism for use in orthopedic implants